Overexpression of phospholipase A2 group IIA in esophageal squamous cell carcinoma and association with cyclooxygenase-2 expression
Asian Pacific Organization for Cancer Prevention
Faculty of Health, Engineering and Science
School of Medical Sciences
Background: Esophageal cancer is one of the most frequently occurring malignancies and the seventh leading cause of cancer-related deaths in the world. The esophageal squamous cell carcinoma (ESCC) is the most common histological type of esophageal cancer worldwide. Materials and Methods: Our goal in this study was to detect phospholipase A2 Group IIA (PLA2G2A) and cyclooxygenase-2 (COX-2) immuno-expression in ESCC in a high-risk population in China. Results: Positive expression of PLA2G2A protein was observed in 57.2% (166/290) of the cases, while COX-2 was found in 257 of 290 samples (88.6%), both PLA2G2A and COX-2 being expressed in 153 cases (52.8%), with a significant agreement (Kappa=0.091, p=0.031).Overexpression of PLA2G2A was significantly correlated with the depth of invasion (p=0.001). Co-expression of PLA2G2A and COX-2 not only significantly correlated with the depth of invasion (p=0.004) but also with TNM stage (p=0.04). Conclusions: Our results showed that in patients with ESCC, PLA2G2A overexpression and PLA2G2A co-expression with COX-2 is significantly correlated with advanced stage. The biological role and pathophysiologic regulation of PLA2G2A and COX-2 overexpression in ESCC deserve further investigation.
This is an Author's Accepted Manuscript of: Zhai Y.-C., Dong B., Wei W.-Q., He Y., Li X.-Q., Cormier R.T., Wang W., Liu F. (2014). Overexpression of phospholipase A2 group IIA in esophageal squamous cell carcinoma and association with cyclooxygenase-2 expression. Asian Pacific Journal of Cancer Prevention, 15(21), 9417-9421. Available here